SPS
CRBU icon

Susquehanna Portfolio Strategies’s Caribou Biosciences CRBU Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-29,883
Closed -$69.6K – 1021
2025
Q3 		$69.6K Buy
+29,883
New +$56.4K ﹤0.01% 1017
2024
Q2 		– Sell
-30,703
Closed -$158K – 570
2024
Q1 		$158K Hold
30,703
– – ﹤0.01% 750
2023
Q4 		$176K Buy
+30,703
New +$152K ﹤0.01% 949

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna Portfolio Strategies's CRBU Position: Q4 2025 in Review

Susquehanna Portfolio Strategies sold out of Caribou Biosciences (CRBU) in Q4 2025, closing a stake of 29,883 shares — an estimated $69.6K sold.

Susquehanna Portfolio Strategies first reported a position in CRBU in Q4 2023 and held it in 3 quarters. The position peaked at $176K in Q4 2023. 124 funds tracked by Wall St. Rank hold CRBU as of Q4 2025.

  • Susquehanna Portfolio Strategies reported no remaining Caribou Biosciences position as of Q4 2025 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 29,883 Caribou Biosciences shares in Q4 2025, an estimated $69.6K.
  • Susquehanna Portfolio Strategies first reported a position in Caribou Biosciences in Q4 2023 and held it in 3 quarters.
  • Susquehanna Portfolio Strategies's Caribou Biosciences position peaked at $176K in Q4 2023.
  • 124 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2025.

Based on Susquehanna Portfolio Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.